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Dietary gluten and its component gliadin are well-known environmental triggers of celiac disease 
and important actors in type-1 diabetes, and are reported to induce alterations in the intestinal 
microbiota. However, research on the impact of gluten on type-2 diabetes in non-celiac subjects is 
more limited. The aim of this study was to investigate the effect of gliadin on glucose homeostasis 
and intestinal ecology in the mouse. Forty male C57BL/6 mice were fed a high-fat diet containing 
either 4% gliadin or no gliadin for 22 weeks. Gliadin consumption significantly increased the HbA1c 
level over time, with a borderline significance of higher HOMA-IR (homeostasis model assessment 
of insulin resistance) after 22 weeks. Sequencing of the V3 region of the bacterial 16S rRNA genes 
showed that gliadin changed the abundance of 81 bacterial taxa, separating the intestinal microbial 
profile of the gliadin consuming mice from the control mice in the principal coordinate analysis 
(PCoA) of weighted UniFrac distance. No difference was found in body weight gain, feed 
consumption or circulating cytokines (IL-1β, IL-6, IFN-γ, TNF-α and IL-10). Our study is the first to 
show that gliadin as part of a defined synthetic feed exacerbates the glycaemia and alters the 
intestinal microbiota composition. Comprehensive analyses of the profile of specific immune cells, 
metabolites and intestinal permeability are in progress to elucidate the mechanism behind the 
observed effects. 
 
